marketcaparena
Search

    IFF

    INTERNATIONAL FLAVORS & FRAGRANCES INC

    Company overview

    Market capitalization
    $21.87B
    Employees
    21,500
    Latest publication
    2026-09-29
    About INTERNATIONAL FLAVORS & FRAGRANCES INC

    International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USD
    Total Revenue1,954,000,000USD2,741,000,000USD2,589,000,000USD2,694,000,000USD2,764,000,000USD2,771,000,000USD2,925,000,000USD2,899,000,000USD
    Cost Of Revenue1,101,000,000USD1,723,000,000USD1,699,000,000USD1,711,000,000USD1,734,000,000USD1,791,000,000USD1,873,000,000USD1,875,000,000USD
    Gross Profit853,000,000USD1,018,000,000USD890,000,000USD983,000,000USD1,030,000,000USD980,000,000USD1,052,000,000USD1,024,000,000USD
    Research Development170,000,000USD166,000,000USD174,000,000USD174,000,000USD182,000,000USD170,000,000USD162,000,000USD166,000,000USD
    Selling General Administrative437,000,000USD427,000,000USD469,000,000USD421,000,000USD483,000,000USD517,000,000USD495,000,000USD490,000,000USD
    Total Operating Expenses695,000,000USD739,000,000USD777,000,000USD757,000,000USD832,000,000USD853,000,000USD803,000,000USD825,000,000USD
    Operating Income158,000,000USD279,000,000USD113,000,000USD226,000,000USD198,000,000USD127,000,000USD249,000,000USD199,000,000USD
    Total Other Income Expense Net-94,000,000USD-70,000,000USD-91,000,000USD-170,000,000USD336,000,000USD-242,000,000USD-154,000,000USD-84,000,000USD
    Interest Income4,000,000USD3,000,000USD49,000,000USD65,000,000USD71,000,000USD82,000,000USD102,000,000USD—
    Interest Expense46,000,000USD44,000,000USD49,000,000USD48,000,000USD61,000,000USD69,000,000USD74,000,000USD83,000,000USD
    Income Before Tax64,000,000USD209,000,000USD22,000,000USD56,000,000USD534,000,000USD-115,000,000USD95,000,000USD115,000,000USD
    Income Tax Expense31,000,000USD39,000,000USD-9,000,000USD15,000,000USD-78,000,000USD-69,000,000USD35,000,000USD54,000,000USD
    Net Income51,000,000USD169,000,000USD31,000,000USD40,000,000USD612,000,000USD-46,000,000USD59,000,000USD60,000,000USD
    Minority Interest0USD-1,000,000USD0USD-1,000,000USD0USD0USD-1,000,000USD-1,000,000USD
    Net Income Applicable To Common Shares50,000,000USD—18,000,000USD40,000,000USD612,000,000USD-46,000,000USD59,000,000USD—
    Unclassified Operating Expenses—146,000,000USD134,000,000USD162,000,000USD167,000,000USD166,000,000USD146,000,000USD169,000,000USD
    Net Interest Income—-41,000,000USD-49,000,000USD-48,000,000USD-61,000,000USD-69,000,000USD-74,000,000USD-83,000,000USD
    Tax Provision—39,000,000USD5,000,000USD15,000,000USD-78,000,000USD-69,000,000USD35,000,000USD54,000,000USD
    Net Income From Continuing Ops—170,000,000USD31,000,000USD41,000,000USD612,000,000USD-46,000,000USD60,000,000USD61,000,000USD
    Ebit—253,000,000USD71,000,000USD104,000,000USD595,000,000USD-46,000,000USD169,000,000USD198,000,000USD
    Ebitda—499,000,000USD308,000,000USD351,000,000USD837,000,000USD197,000,000USD417,000,000USD476,000,000USD
    Depreciation And Amortization—246,000,000USD237,000,000USD247,000,000USD242,000,000USD243,000,000USD248,000,000USD278,000,000USD
    Reconciled Depreciation—246,000,000USD237,000,000USD247,000,000USD242,000,000USD243,000,000USD248,000,000USD278,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20202020-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USD
    Total Revenue10,890,000,000USD5,084,000,000USD3,398,719,000USD3,116,350,000USD3,023,189,000USD3,088,533,000USD2,952,896,000USD2,821,446,000USD
    Cost Of Revenue6,952,000,000USD2,998,000,000USD1,926,256,000USD1,720,787,000USD1,671,590,000USD1,726,383,000USD1,668,691,000USD1,645,912,000USD
    Gross Profit3,938,000,000USD2,086,000,000USD1,472,463,000USD1,395,563,000USD1,351,599,000USD1,362,150,000USD1,284,205,000USD1,175,534,000USD
    Research Development694,000,000USD357,000,000USD295,469,000USD258,863,000USD246,101,000USD253,640,000USD259,838,000USD233,713,000USD
    Selling General Administrative1,834,000,000USD966,128,000USD557,311,000USD566,224,000USD509,557,000USD514,891,000USD505,877,000USD453,535,000USD
    Unclassified Operating Expenses568,000,000USD196,872,000USD67,053,000USD17,521,000USD————
    Total Operating Expenses3,096,000,000USD1,520,000,000USD919,833,000USD842,608,000USD763,252,000USD769,829,000USD767,866,000USD688,916,000USD
    Operating Income842,000,000USD566,000,000USD552,630,000USD552,955,000USD588,347,000USD592,321,000USD516,339,000USD486,618,000USD
    Interest Income229,000,000USD131,802,000USD75,420,000USD26,168,000USD37,418,000USD———
    Interest Expense229,000,000USD132,000,000USD65,363,000USD52,989,000USD46,062,000USD46,067,000USD46,767,000USD41,753,000USD
    Net Interest Income-229,000,000USD-131,802,000USD-65,363,000USD-52,989,000USD————
    Income Before Tax-412,000,000USD441,000,000USD537,045,000USD523,717,000USD539,101,000USD549,061,000USD485,210,000USD443,415,000USD
    Income Tax Expense-53,000,000USD74,000,000USD241,380,000USD118,686,000USD119,854,000USD134,518,000USD131,666,000USD189,281,000USD
    Tax Provision-39,000,000USD73,999,000USD241,380,000USD118,686,000USD119,854,000USD———
    Net Income-361,000,000USD365,000,000USD295,665,000USD405,031,000USD419,247,000USD414,543,000USD353,544,000USD254,134,000USD
    Net Income From Continuing Ops-359,000,000USD307,531,000USD301,605,000USD394,699,000USD473,364,000USD319,505,000USD378,808,000USD212,586,000USD
    Ebit-183,000,000USD573,000,000USD602,408,000USD576,706,000USD585,163,000USD595,128,000USD531,977,000USD485,168,000USD
    Ebitda779,000,000USD898,000,000USD720,375,000USD679,175,000USD674,760,000USD684,482,000USD615,204,000USD561,835,000USD
    Depreciation And Amortization962,000,000USD325,000,000USD117,967,000USD102,469,000USD89,597,000USD89,354,000USD83,227,000USD76,667,000USD
    Reconciled Depreciation962,000,000USD325,360,000USD117,967,000USD—————
    Total Other Income Expense Net-1,254,000,000USD-125,000,000USD-15,585,000USD-29,238,000USD-49,246,000USD-43,260,000USD-31,129,000USD-43,203,000USD
    Minority Interest-2,000,000USD4,144,000USD5,092,000USD4,890,000USD4,672,000USD4,128,000USD——
    Net Income Applicable To Common Shares-374,000,000USD363,228,000USD295,665,000USD405,031,000USD419,247,000USD414,543,000USD353,544,000USD254,134,000USD
    Non Operating Income Net Other—6,689,000USD20,965,000USD9,350,000USD-3,184,000USD2,807,000USD15,638,000USD-1,450,000USD
    Selling And Marketing Expenses————10,530,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets25,154,000,000USD25,144,000,000USD25,539,000,000USD25,768,000,000USD26,121,000,000USD28,265,000,000USD28,667,000,000USD29,928,000,000USD
    Cash And Equivalents569,000,000USD—590,000,000USD621,000,000USD816,000,000USD613,000,000USD469,000,000USD567,000,000USD
    Total Current Assets9,088,000,000USD5,437,000,000USD5,594,000,000USD5,842,000,000USD5,928,000,000USD8,633,000,000USD7,993,000,000USD8,423,000,000USD
    Other Current Assets706,000,000USD496,000,000USD639,000,000USD893,000,000USD553,000,000USD3,751,000,000USD3,299,000,000USD3,586,000,000USD
    Other Non Current Assets1,020,000,000USD———————
    Total Liabilities11,145,000,000USD———————
    Total Current Liabilities4,410,000,000USD3,645,000,000USD3,933,000,000USD4,069,000,000USD3,183,000,000USD4,607,000,000USD4,333,000,000USD3,218,000,000USD
    Other Current Liabilities891,000,000USD———————
    Other Non Current Liabilities551,000,000USD———————
    Total Stockholder Equity13,976,000,000USD14,120,000,000USD14,154,000,000USD14,241,000,000USD14,404,000,000USD13,177,000,000USD13,876,000,000USD14,775,000,000USD
    Total Equity Including Noncontrolling Interest14,009,000,000USD———————
    Short Long Term Debt1,064,000,000USD1,078,000,000USD1,254,000,000USD1,308,000,000USD500,000,000USD1,689,000,000USD1,413,000,000USD468,000,000USD
    Long Term Debt4,735,000,000USD4,739,000,000USD4,740,000,000USD4,741,000,000USD5,684,000,000USD7,601,000,000USD7,564,000,000USD8,631,000,000USD
    Net Receivables118,000,000USD2,009,000,000USD2,001,000,000USD2,005,000,000USD2,055,000,000USD1,894,000,000USD1,969,000,000USD1,935,000,000USD
    Inventory1,505,000,000USD2,370,000,000USD2,364,000,000USD2,323,000,000USD2,504,000,000USD2,375,000,000USD2,256,000,000USD2,335,000,000USD
    Property Plant Equipment Net3,169,000,000USD4,601,000,000USD4,640,000,000USD4,463,000,000USD4,554,000,000USD4,379,000,000USD4,339,000,000USD4,446,000,000USD
    Goodwill8,145,000,000USD———————
    Intangible Assets3,732,000,000USD5,867,000,000USD6,043,000,000USD6,183,000,000USD6,430,000,000USD6,383,000,000USD6,445,000,000USD6,770,000,000USD
    Accounts Payable1,064,000,000USD1,371,000,000USD1,287,000,000USD1,284,000,000USD1,348,000,000USD1,325,000,000USD1,283,000,000USD1,211,000,000USD
    Short Term Debt964,000,000USD1,078,000,000USD1,358,000,000USD1,401,000,000USD595,000,000USD1,775,000,000USD1,495,000,000USD556,000,000USD
    Common Stock35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD
    Retained Earnings-3,402,000,000USD-3,350,000,000USD-3,417,000,000USD-3,345,000,000USD-3,215,000,000USD-3,725,000,000USD-2,605,000,000USD-2,457,000,000USD
    Accumulated Other Comprehensive Income-1,588,000,000USD-1,511,000,000USD-1,430,000,000USD-1,463,000,000USD-1,415,000,000USD-2,123,000,000USD-2,527,000,000USD-1,760,000,000USD
    Total Liab—10,991,000,000USD11,353,000,000USD11,495,000,000USD11,685,000,000USD15,052,000,000USD14,756,000,000USD15,118,000,000USD
    Other Current Liab—1,196,000,000USD1,288,000,000USD1,384,000,000USD976,000,000USD1,324,000,000USD1,366,000,000USD1,328,000,000USD
    Capital Stock—35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD
    Good Will—8,220,000,000USD8,269,000,000USD8,264,000,000USD8,283,000,000USD8,030,000,000USD9,080,000,000USD9,349,000,000USD
    Cash—562,000,000USD590,000,000USD621,000,000USD816,000,000USD613,000,000USD469,000,000USD567,000,000USD
    Cash And Short Term Investments—562,000,000USD590,000,000USD621,000,000USD816,000,000USD613,000,000USD469,000,000USD567,000,000USD
    Net Debt—5,255,000,000USD6,061,000,000USD6,617,000,000USD6,034,000,000USD9,298,000,000USD9,152,000,000USD9,225,000,000USD
    Short Long Term Debt Total—5,817,000,000USD6,651,000,000USD7,238,000,000USD6,850,000,000USD9,911,000,000USD9,621,000,000USD9,792,000,000USD
    Long Term Investments—15,000,000USD15,000,000USD15,000,000USD16,000,000USD11,000,000USD10,000,000USD10,000,000USD
    Property Plant Equipment Gross—7,467,000,000USD7,436,000,000USD7,237,000,000USD7,265,000,000USD6,939,000,000USD6,767,000,000USD6,940,000,000USD
    Common Stock Shares Outstanding—257,000,000shares257,000,000shares257,000,000shares257,000,000shares256,000,000shares256,000,000shares257,000,000shares
    Non Current Assets Total—19,707,000,000USD19,945,000,000USD19,892,000,000USD20,193,000,000USD19,632,000,000USD20,674,000,000USD21,505,000,000USD
    Non Current Liabilities Total—7,346,000,000USD7,420,000,000USD7,426,000,000USD8,502,000,000USD10,445,000,000USD10,423,000,000USD11,900,000,000USD
    Non Current Liabilities Other—548,000,000USD582,000,000USD611,000,000USD680,000,000USD592,000,000USD566,000,000USD613,000,000USD
    Non Currrent Assets Other—706,000,000USD693,000,000USD479,000,000USD666,000,000USD570,000,000USD560,000,000USD529,000,000USD
    Net Working Capital—1,792,000,000USD1,661,000,000USD1,807,000,000USD2,745,000,000USD4,026,000,000USD3,660,000,000USD5,205,000,000USD
    Unclassified Non Current Assets—298,000,000USD-1,317,000,000USD—-426,000,000USD-399,000,000USD-389,000,000USD-529,000,000USD
    Unclassified Current Liabilities—-1,078,000,000USD-1,254,000,000USD-1,308,000,000USD-236,000,000USD-1,506,000,000USD-1,224,000,000USD-345,000,000USD
    Unclassified Non Current Liabilities—2,059,000,000USD2,098,000,000USD2,074,000,000USD2,138,000,000USD2,252,000,000USD2,293,000,000USD2,656,000,000USD
    Unclassified Equity—18,911,000,000USD18,931,000,000USD18,979,000,000USD18,964,000,000USD18,955,000,000USD18,938,000,000USD18,922,000,000USD
    Other Assets——1,602,000,000USD678,000,000USD670,000,000USD658,000,000USD629,000,000USD930,000,000USD
    Short Term Investments———152,000,000USD————
    Unclassified Current Assets———-152,000,000USD————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets25,539,000,000USD28,667,000,000USD30,978,000,000USD35,390,000,000USD39,658,000,000USD13,555,671,000USD13,287,411,000USD12,889,395,000USD
    Intangible Assets6,043,000,000USD6,445,000,000USD8,357,000,000USD9,082,000,000USD10,506,000,000USD2,727,175,000USD2,851,935,000USD3,039,322,000USD
    Other Current Assets639,000,000USD3,299,000,000USD861,000,000USD1,970,000,000USD1,545,000,000USD156,000,000USD188,646,000USD13,625,000USD
    Total Liab11,353,000,000USD14,756,000,000USD16,336,000,000USD17,597,000,000USD18,436,000,000USD7,135,084,000USD6,958,820,000USD6,764,215,000USD
    Total Stockholder Equity14,154,000,000USD13,876,000,000USD14,611,000,000USD17,793,000,000USD21,082,000,000USD6,311,153,000USD6,217,304,000USD6,032,951,000USD
    Other Current Liab1,288,000,000USD1,366,000,000USD1,216,000,000USD-542,000,000USD1,216,000,000USD607,646,000USD554,315,000USD560,678,000USD
    Common Stock35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD16,065,999USD16,065,999USD16,065,999USD
    Capital Stock35,000,000USD35,000,000USD35,000,000USD35,000,000USD35,000,000USD16,066,000USD16,066,000USD16,066,000USD
    Retained Earnings-3,417,000,000USD-2,605,000,000USD-2,439,000,000USD955,000,000USD3,641,000,000USD4,156,167,999USD4,117,804,000USD3,956,221,000USD
    Good Will8,269,000,000USD9,080,000,000USD10,635,000,000USD13,355,000,000USD16,414,000,000USD5,593,252,000USD5,497,596,000USD5,378,388,000USD
    Other Assets1,602,000,000USD629,000,000USD727,000,000USD667,000,000USD1,383,000,000USD717,260,000USD315,754,000USD288,673,000USD
    Cash590,000,000USD469,000,000USD703,000,000USD493,000,000USD711,000,000USD650,000,000USD606,823,000USD634,897,000USD
    Cash And Equivalents590,000,000USD469,000,000USD703,000,000USD483,000,000USD711,000,000USD649,541,000USD606,823,000USD634,897,000USD
    Cash And Short Term Investments590,000,000USD469,000,000USD703,000,000USD493,000,000USD711,000,000USD650,000,000USD606,823,000USD634,897,000USD
    Total Current Assets5,594,000,000USD7,993,000,000USD6,293,000,000USD7,432,000,000USD6,987,000,000USD3,059,799,000USD2,942,544,000USD2,941,860,000USD
    Total Current Liabilities3,933,000,000USD4,333,000,000USD3,758,000,000USD3,738,000,000USD3,633,000,000USD1,904,000,000USD1,552,190,000USD1,128,311,000USD
    Net Debt6,061,000,000USD9,152,000,000USD10,114,000,000USD10,477,000,000USD11,484,000,000USD4,068,944,000USD4,054,018,000USD3,904,537,000USD
    Short Term Debt1,358,000,000USD1,495,000,000USD970,000,000USD597,000,000USD741,000,000USD678,000,000USD424,633,000USD48,642,000USD
    Short Long Term Debt1,254,000,000USD1,413,000,000USD885,000,000USD597,000,000USD632,000,000USD634,159,000USD384,958,000USD48,642,000USD
    Short Long Term Debt Total6,651,000,000USD9,621,000,000USD10,823,000,000USD10,982,000,000USD12,199,000,000USD4,725,780,000USD4,677,963,000USD4,553,059,000USD
    Long Term Debt4,740,000,000USD7,564,000,000USD9,186,000,000USD10,373,000,000USD10,768,000,000USD3,779,359,000USD3,997,438,000USD4,504,417,000USD
    Long Term Investments15,000,000USD10,000,000USD11,000,000USD10,000,000USD86,000,000USD5,000,000USD—31,470,000USD
    Net Receivables2,001,000,000USD1,969,000,000USD2,091,000,000USD1,818,000,000USD2,215,000,000USD1,122,000,000USD1,024,007,000USD1,214,801,000USD
    Inventory2,364,000,000USD2,256,000,000USD2,638,000,000USD3,151,000,000USD2,516,000,000USD1,132,000,000USD1,123,068,000USD1,078,537,000USD
    Accounts Payable1,287,000,000USD1,283,000,000USD1,378,000,000USD1,418,000,000USD1,532,000,000USD556,000,000USD510,372,000USD471,382,000USD
    Property Plant Equipment Net4,640,000,000USD4,339,000,000USD4,955,000,000USD4,203,000,000USD5,156,000,000USD1,765,224,000USD1,679,582,000USD1,241,152,000USD
    Property Plant Equipment Gross7,436,000,000USD6,767,000,000USD7,357,000,000USD6,838,000,000USD6,949,000,000USD1,458,185,000USD1,679,582,000USD1,241,152,000USD
    Accumulated Other Comprehensive Income-1,430,000,000USD-2,527,000,000USD-1,896,000,000USD-2,169,000,000USD-1,423,000,000USD-697,540,999USD-716,894,000USD-702,227,000USD
    Common Stock Shares Outstanding256,000,000shares256,000,000shares255,000,000shares255,000,000shares243,000,000shares113,630,000shares113,307,000shares88,121,000shares
    Non Current Assets Total19,945,000,000USD20,674,000,000USD24,685,000,000USD27,958,000,000USD32,671,000,000USD10,495,000,000USD10,344,867,000USD9,947,535,000USD
    Non Current Liabilities Total7,420,000,000USD10,423,000,000USD12,578,000,000USD13,859,000,000USD14,803,000,000USD5,231,000,000USD5,406,630,000USD5,635,904,000USD
    Non Current Liabilities Other582,000,000USD566,000,000USD560,000,000USD3,486,000,000USD4,054,000,000USD858,630,000USD767,736,000USD444,242,000USD
    Non Currrent Assets Other693,000,000USD560,000,000USD449,000,000USD1,150,000,000USD427,000,000USD208,000,000USD190,202,000USD168,203,000USD
    Net Working Capital1,661,000,000USD3,660,000,000USD2,535,000,000USD3,694,000,000USD3,354,000,000USD1,156,073,000USD1,390,354,000USD1,813,549,000USD
    Unclassified Non Current Assets-1,317,000,000USD-389,000,000USD-449,000,000USD-509,000,000USD-1,301,000,000USD-520,911,000USD-190,202,000USD-199,673,000USD
    Unclassified Current Liabilities-1,254,000,000USD-1,224,000,000USD-1,092,000,000USD-1,139,000,000USD-488,000,000USD-571,805,000USD-684,948,000USD—
    Unclassified Non Current Liabilities2,098,000,000USD2,293,000,000USD2,832,000,000USD-2,956,000,000USD-6,591,000,000USD-1,452,357,000USD-1,153,300,000USD-1,131,487,000USD
    Unclassified Equity18,931,000,000USD18,938,000,000USD18,876,000,000USD18,937,000,000USD19,791,000,000USD3,837,335,001USD3,807,086,001USD3,777,543,001USD
    Current Deferred Revenue——401,000,000USD2,265,000,000USD-1,532,000,000USD-555,687,000USD362,860,000USD3,200,000USD
    Other Liab———2,956,000,000USD4,054,000,000USD1,451,999,000USD1,153,300,000USD1,131,487,000USD
    Net Tangible Assets———-4,753,000,000USD-5,822,000,000USD-1,911,722,000USD-2,033,184,000USD-2,302,953,000USD
    Deferred Long Term Liab————2,518,000,000USD593,369,000USD641,456,000USD687,245,000USD
    Treasury Stock————-997,000,000USD-1,016,941,000USD-1,022,824,000USD-1,030,718,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation464,000,000USD
    Stock Based Compensation51,000,000USD
    Deferred Income Tax-37,000,000USD
    Other Non Cash Items0USD
    Change To Account Receivables-188,000,000USD
    Change To Inventory-45,000,000USD
    Change To Liabilities288,000,000USD
    Change In Working Capital-8,000,000USD
    Operating Cash Flow679,000,000USD
    Capital Expenditures-301,000,000USD
    Unclassified Investing Cash Flow168,000,000USD
    Investing Cash Flow-133,000,000USD
    Net Debt Issuance-6,000,000USD
    Net Common Stock Issuance-89,000,000USD
    Common Dividends Paid-204,000,000USD
    Other Financing Activities-8,000,000USD
    Unclassified Financing Cash Flow-258,000,000USD
    Financing Cash Flow-565,000,000USD
    Effect Of Forex Changes On Cash-2,000,000USD
    Change In Cash-21,000,000USD
    End Cash Flow569,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income170,000,000USD40,000,000USD612,000,000USD-1,017,000,000USD-46,000,000USD60,000,000USD172,000,000USD61,000,000USD
    Depreciation246,000,000USD333,000,000USD242,000,000USD236,000,000USD243,000,000USD248,000,000USD246,000,000USD278,000,000USD
    Stock Based Compensation16,000,000USD18,000,000USD32,000,000USD19,000,000USD18,000,000USD16,000,000USD25,000,000USD18,000,000USD
    Other Non Cash Items2,000,000USD9,000,000USD-410,000,000USD1,148,000,000USD148,000,000USD45,000,000USD-34,000,000USD-9,000,000USD
    Change To Account Receivables-107,000,000USD-89,000,000USD10,000,000USD-116,000,000USD59,000,000USD17,000,000USD-3,000,000USD-290,000,000USD
    Change To Inventory-33,000,000USD-5,000,000USD-32,000,000USD-92,000,000USD-31,000,000USD127,000,000USD-30,000,000USD34,000,000USD
    Change In Working Capital-162,000,000USD-196,000,000USD-133,000,000USD-198,000,000USD181,000,000USD48,000,000USD-104,000,000USD-240,000,000USD
    Total Cash From Operating Activities257,000,000USD164,000,000USD241,000,000USD127,000,000USD368,000,000USD366,000,000USD237,000,000USD99,000,000USD
    Capital Expenditures-165,000,000USD-134,000,000USD-95,000,000USD-179,000,000USD-160,000,000USD-108,000,000USD-82,000,000USD-118,000,000USD
    Free Cash Flow92,000,000USD30,000,000USD146,000,000USD-52,000,000USD208,000,000USD258,000,000USD155,000,000USD-19,000,000USD
    Investments-10,000,000USD-115,000,000USD2,698,000,000USD-157,000,000USD-260,000,000USD-78,000,000USD742,000,000USD-78,000,000USD
    Total Cashflows From Investing Activities23,000,000USD-115,000,000USD2,698,000,000USD-157,000,000USD-260,000,000USD-78,000,000USD742,000,000USD-78,000,000USD
    Net Borrowings-160,000,000USD-130,000,000USD-2,689,000,000USD276,000,000USD-56,000,000USD-314,000,000USD——
    Total Cash From Financing Activities-301,000,000USD-237,000,000USD-2,823,000,000USD169,000,000USD-162,000,000USD-421,000,000USD-1,063,000,000USD40,000,000USD
    Dividends Paid-102,000,000USD-102,000,000USD-102,000,000USD-102,000,000USD-103,000,000USD-102,000,000USD-102,000,000USD-207,000,000USD
    Sale Purchase Of Stock-35,000,000USD-1,000,000USD-22,000,000USD0USD-1,000,000USD—-13,000,000USD-1,000,000USD
    Change In Cash-28,000,000USD-195,000,000USD203,000,000USD144,000,000USD-98,000,000USD-104,000,000USD-68,000,000USD30,000,000USD
    Begin Period Cash Flow590,000,000USD816,000,000USD613,000,000USD469,000,000USD567,000,000USD671,000,000USD739,000,000USD709,000,000USD
    End Period Cash Flow562,000,000USD621,000,000USD816,000,000USD613,000,000USD469,000,000USD567,000,000USD671,000,000USD739,000,000USD
    Other Cashflows From Investing Activities-10,000,000USD-76,000,000USD90,000,000USD22,000,000USD-99,000,000USD894,000,000USD13,000,000USD3,000,000USD
    Other Cashflows From Financing Activities-4,000,000USD-4,000,000USD-10,000,000USD-5,000,000USD-2,000,000USD-5,000,000USD-51,000,000USD-3,000,000USD
    Unclassified Operating Cash Flow-15,000,000USD-40,000,000USD-102,000,000USD-61,000,000USD-176,000,000USD-51,000,000USD-68,000,000USD-9,000,000USD
    Unclassified Investing Cash Flow208,000,000USD210,000,000USD—157,000,000USD259,000,000USD-786,000,000USD69,000,000USD115,000,000USD
    Unclassified Financing Cash Flow——————-897,000,000USD251,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-361,000,000USD247,000,000USD-2,563,000,000USD-1,836,000,000USD279,000,000USD367,372,000USD460,268,000USD339,781,000USD
    Depreciation962,000,000USD1,015,000,000USD1,142,000,000USD1,179,000,000USD1,156,000,000USD325,360,000USD323,330,000USD173,792,000USD
    Stock Based Compensation88,000,000USD77,000,000USD65,000,000USD49,000,000USD54,000,000USD35,798,000USD34,482,000USD29,401,000USD
    Other Non Cash Items940,000,000USD150,000,000USD2,679,000,000USD2,320,000,000USD337,000,000USD-20,443,000USD-21,347,000USD2,930,000USD
    Change To Account Receivables-68,000,000USD-217,000,000USD51,000,000USD-117,000,000USD-169,000,000USD-60,979,000USD-9,467,000USD-49,958,000USD
    Change To Inventory-41,000,000USD-34,000,000USD605,000,000USD-893,000,000USD-363,000,000USD17,924,000USD-62,129,000USD-117,641,000USD
    Change In Working Capital-421,000,000USD-115,000,000USD485,000,000USD-1,073,000,000USD-153,000,000USD73,729,000USD-38,489,000USD-128,603,000USD
    Total Cash From Operating Activities850,000,000USD1,070,000,000USD1,439,000,000USD345,000,000USD1,437,000,000USD714,098,000USD699,000,000USD437,575,000USD
    Capital Expenditures-594,000,000USD-468,000,000USD-503,000,000USD-506,000,000USD-397,000,000USD-191,794,000USD-242,000,000USD-173,420,000USD
    Free Cash Flow256,000,000USD602,000,000USD936,000,000USD-161,000,000USD1,040,000,000USD522,304,000USD457,000,000USD264,155,000USD
    Investments105,000,000USD326,000,000USD496,000,000USD745,000,000USD-18,000,000USD-14,597,000USD25,900,000USD7,515,000USD
    Total Cashflows From Investing Activities2,269,000,000USD326,000,000USD574,000,000USD745,000,000USD-18,000,000USD-187,463,000USD-225,866,000USD-5,013,235,000USD
    Net Borrowings-2,599,000,000USD-1,030,000,000USD-941,000,000USD-344,000,000USD-606,000,000USD-150,635,000USD-156,282,000USD2,845,522,000USD
    Total Cash From Financing Activities-3,091,000,000USD-1,606,000,000USD-1,851,000,000USD-1,229,000,000USD-1,304,000,000USD-511,570,000USD-505,000,000USD4,870,703,000USD
    Dividends Paid-409,000,000USD-514,000,000USD-826,000,000USD-810,000,000USD-667,000,000USD-322,584,000USD-314,000,000USD-230,218,000USD
    Sale Purchase Of Stock-38,000,000USD-16,000,000USD-13,000,000USD-21,000,000USD-9,000,000USD-21,566,000USD-11,000,000USD-15,475,000USD
    Change In Cash119,000,000USD-240,000,000USD216,000,000USD-216,000,000USD56,000,000USD35,927,000USD-24,577,000USD280,476,000USD
    Begin Period Cash Flow471,000,000USD709,000,000USD493,000,000USD716,000,000USD660,000,000USD623,945,000USD648,522,000USD368,046,000USD
    End Period Cash Flow590,000,000USD469,000,000USD709,000,000USD500,000,000USD716,000,000USD659,872,000USD623,945,000USD648,522,000USD
    Other Cashflows From Investing Activities105,000,000USD16,000,000USD27,000,000USD1,251,000,000USD379,000,000USD18,928,000USD50,072,000USD13,339,000USD
    Other Cashflows From Financing Activities-45,000,000USD-46,000,000USD-84,000,000USD302,000,000USD296,000,000USD158,444,000USD-35,000,000USD2,237,206,000USD
    Unclassified Operating Cash Flow-358,000,000USD-304,000,000USD-369,000,000USD-294,000,000USD-236,000,000USD-67,718,000USD-59,244,000USD20,274,000USD
    Unclassified Investing Cash Flow2,653,000,000USD452,000,000USD554,000,000USD-745,000,000USD18,000,000USD—-59,838,000USD-4,860,669,000USD
    Change To Liabilities———-57,000,000USD419,000,000USD102,075,000USD30,735,000USD59,087,000USD
    Unclassified Financing Cash Flow———-356,000,000USD-318,000,000USD-175,229,000USD11,282,000USD—
    Exchange Rate Changes————-59,000,000USD20,862,000USD7,381,000USD-14,567,000USD
    Cash And Cash Equivalents Changes————56,000,000USD35,927,000USD-24,577,000USD280,476,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentHealth Biosciences601,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentScent665,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentTaste688,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentFood Ingredients839,000,000USD0000051253-26-000017
    Q1 2026Quarterly · 2026-03-31SegmentHealth Biosciences595,000,000USD0000051253-26-000017
    Q1 2026Quarterly · 2026-03-31SegmentScent651,000,000USD0000051253-26-000017
    Q1 2026Quarterly · 2026-03-31SegmentTaste656,000,000USD0000051253-26-000017
    FY 2025Yearly · 2025-12-31GeographyAsia2,546,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31GeographyEMEA3,727,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31GeographyLatin America1,422,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31GeographyNorth America3,195,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31SegmentFood Ingredients3,278,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31SegmentHealth And Biosciences2,283,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31SegmentPharma Solutions369,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31SegmentScent2,479,000,000USD0000051253-26-000006
    FY 2025Yearly · 2025-12-31SegmentTaste2,481,000,000USD0000051253-26-000006
    Q3 2025Quarterly · 2025-09-30SegmentFood Ingredients830,000,000USD0000051253-25-000049
    Q3 2025Quarterly · 2025-09-30SegmentHealth Biosciences577,000,000USD0000051253-25-000049
    Q3 2025Quarterly · 2025-09-30SegmentScent652,000,000USD0000051253-25-000049
    Q3 2025Quarterly · 2025-09-30SegmentTaste635,000,000USD0000051253-25-000049
    Q2 2025Quarterly · 2025-06-30SegmentFood Ingredients850,000,000USD0000051253-25-000042
    Q2 2025Quarterly · 2025-06-30SegmentHealth Biosciences577,000,000USD0000051253-25-000042
    Q2 2025Quarterly · 2025-06-30SegmentPharma Solutions103,000,000USD0000051253-25-000042
    Q2 2025Quarterly · 2025-06-30SegmentScent603,000,000USD0000051253-25-000042
    Q2 2025Quarterly · 2025-06-30SegmentTaste631,000,000USD0000051253-25-000042
    Q1 2025Quarterly · 2025-03-31SegmentFood Ingredients796,000,000USD0000051253-26-000017
    Q1 2025Quarterly · 2025-03-31SegmentHealth Biosciences540,000,000USD0000051253-26-000017
    Q1 2025Quarterly · 2025-03-31SegmentPharma Solutions266,000,000USD0000051253-26-000017
    Q1 2025Quarterly · 2025-03-31SegmentScent614,000,000USD0000051253-26-000017
    Q1 2025Quarterly · 2025-03-31SegmentTaste627,000,000USD0000051253-26-000017
    FY 2024Yearly · 2024-12-31GeographyAsia2,731,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31GeographyEMEA3,840,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31GeographyLatin America1,473,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31GeographyNorth America3,440,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31SegmentFood Ingredients3,365,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31SegmentHealth And Biosciences2,203,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31SegmentPharma Solutions1,049,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31SegmentScent2,439,000,000USD0000051253-26-000006
    FY 2024Yearly · 2024-12-31SegmentTaste2,428,000,000USD0000051253-26-000006
    Q3 2024Quarterly · 2024-09-30SegmentFood Ingredients843,000,000USD0000051253-25-000049
    Q3 2024Quarterly · 2024-09-30SegmentHealth Biosciences568,000,000USD0000051253-25-000049
    Q3 2024Quarterly · 2024-09-30SegmentPharma Solutions278,000,000USD0000051253-25-000049
    Q3 2024Quarterly · 2024-09-30SegmentScent613,000,000USD0000051253-25-000049
    Q3 2024Quarterly · 2024-09-30SegmentTaste623,000,000USD0000051253-25-000049
    Q2 2024Quarterly · 2024-06-30SegmentFood Ingredients847,000,000USD0000051253-25-000042
    Q2 2024Quarterly · 2024-06-30SegmentHealth Biosciences556,000,000USD0000051253-25-000042
    Q2 2024Quarterly · 2024-06-30SegmentPharma Solutions273,000,000USD0000051253-25-000042
    Q2 2024Quarterly · 2024-06-30SegmentScent603,000,000USD0000051253-25-000042
    Q2 2024Quarterly · 2024-06-30SegmentTaste610,000,000USD0000051253-25-000042
    Q1 2024Quarterly · 2024-03-31SegmentFood Ingredients856,000,000USD0000051253-25-000027
    Q1 2024Quarterly · 2024-03-31SegmentHealth Biosciences529,000,000USD0000051253-25-000027
    Q1 2024Quarterly · 2024-03-31SegmentPharma Solutions250,000,000USD0000051253-25-000027
    Q1 2024Quarterly · 2024-03-31SegmentScent645,000,000USD0000051253-25-000027
    Q1 2024Quarterly · 2024-03-31SegmentTaste619,000,000USD0000051253-25-000027
    FY 2023Yearly · 2023-12-31GeographyAsia2,677,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31GeographyEMEA3,834,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31GeographyLatin America1,491,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31GeographyNorth America3,477,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31SegmentFood Ingredients3,692,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31SegmentHealth And Biosciences2,071,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31SegmentPharma Solutions1,020,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31SegmentScent2,393,000,000USD0000051253-26-000006
    FY 2023Yearly · 2023-12-31SegmentTaste2,303,000,000USD0000051253-26-000006
    FY 2022Yearly · 2022-12-31GeographyAsia2,876,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31GeographyEMEA4,219,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31GeographyLatin America1,492,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31GeographyNorth America3,853,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31SegmentHealth And Biosciences2,339,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31SegmentNourish6,829,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31SegmentPharma Solutions971,000,000USD0000051253-25-000013
    FY 2022Yearly · 2022-12-31SegmentScent2,301,000,000USD0000051253-25-000013
    FY 2021Yearly · 2021-12-31GeographyAsia2,728,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31GeographyEMEA4,093,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31GeographyLatin America1,336,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31GeographyNorth America3,499,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31SegmentHealth Biosciences2,329,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31SegmentNourish6,264,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31SegmentPharma Solutions809,000,000USD0000051253-24-000006
    FY 2021Yearly · 2021-12-31SegmentScent2,254,000,000USD0000051253-24-000006
    FY 2020Yearly · 2020-12-31GeographyAsia1,162,000,000USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31GeographyEMEA1,987,000,000USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31GeographyLatin America707,000,000USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31GeographyNorth America1,228,000,000USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31SegmentHealth Biosciences134,000,000USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31SegmentNourish2,886,000,000USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31SegmentPharma Solutions0USD0000051253-23-000009
    FY 2020Yearly · 2020-12-31SegmentScent2,064,000,000USD0000051253-23-000009
    FY 2019Yearly · 2019-12-31GeographyAsia1,163,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31GeographyEMEA2,082,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31GeographyLatin America725,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31GeographyNorth America1,170,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31SegmentHealth Biosciences129,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31SegmentNourish2,978,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31SegmentPharma Solutions0USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31SegmentScent2,033,000,000USD0000051253-22-000007
    FY 2019Yearly · 2019-12-31ProductFlavors2,850,498,000USD0000051253-20-000007
    FY 2019Yearly · 2019-12-31ProductFragrance Ingredients745,752,000USD0000051253-20-000007
    FY 2019Yearly · 2019-12-31ProductFragrances1,543,834,000USD0000051253-20-000007
    Q2 2019Quarterly · 2019-06-30GeographyAsia293,257,000USD0000051253-19-000018
    Q2 2019Quarterly · 2019-06-30GeographyEMEA528,094,000USD0000051253-19-000018

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.